Literature DB >> 22454877

The renal excretion of mexiletine (Kö 1173) under controlled conditions of urine pH.

M A Kiddie, C M Kaye.   

Abstract

Entities:  

Year:  1974        PMID: 22454877      PMCID: PMC1402406          DOI: 10.1111/j.1365-2125.1974.tb00214.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  RHYTHMIC URINARY EXCRETION OF AMPHETAMINE IN MAN.

Authors:  A H BECKETT; M ROWLAND
Journal:  Nature       Date:  1964-12-19       Impact factor: 49.962

2.  Urinary excretion kinetics of amphetamine in man.

Authors:  A H Beckett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1965-10       Impact factor: 3.765

3.  Treatment of ventricular arrhythmias with mexiletine (Kö 1173).

Authors:  R G Talbot; J Nimmo; D G Julian; R A Clark; J M Neilson; L F Prescott
Journal:  Lancet       Date:  1973-08-25       Impact factor: 79.321

4.  Preliminary studies on the pharmacology of an antidysrhythmic, Kö 1173, in man.

Authors:  M A Kiddie; R B Royds; T R Shaw
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

5.  Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine.

Authors:  J G Kelly; J Nimmo; R Rae; R G Shanks; L F Prescott
Journal:  J Pharm Pharmacol       Date:  1973-07       Impact factor: 3.765

6.  Mexiletine (Kö 1173) in the management of ventricular dysrhythmias.

Authors:  N P Campbell; J G Kelly; R G Shanks; N C Chaturvedi; J E Strong; J F Pantridge
Journal:  Lancet       Date:  1973-08-25       Impact factor: 79.321

  6 in total
  1 in total

Review 1.  Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Authors:  K A Muhiddin; P Turner
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.